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INTRODUCTION
ST11 is the most frequent clone of K. pneumoniae, which is 
disseminated worldwide carrying the carbapenemase and 
ESBL genes and has been designated an epidemic clone 
III (ECIII) (Damjanova et al., 2008). ST11 is a single-lo-
cus variant of the international hyper-epidemic lineage 
ST258, showing rapid dissemination over other clones as 
good colonizers that capture and accumulate the resis-
tance determinants. In addition, emergence of K. pneumo-
niae ST11 co-producing KPC-2 and 16S rRNA methylase 
rmtB is posing a greater threat to antimicrobial therapy 
and causing severe complications like bacteremia and UTI 
(urinary tract infection) (Ko et al., 2010; Li et al., 2008). 
In K. pneumoniae, multidrug resistance is offered by large 
conjugative plasmids along with increasing efflux pump 
activity and altered profile of outer membrane porins that 
control the entry of antibiotics into the cell wall (Institute 
of medicine (US) forum on Microbial Threats Workshop, 
2010). To date, only 3 carbapenem-resistant K. pneumoni-
ae have been sequenced and their resistance mechanisms 
illustrated and there are no studies on the mechanism 
responsible for the multidrug resistance of ST11 isolates 
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producing ESBLs (Hudson et al., 2014; Zhu et al., 2013; 
Liu et al., 2012). Extended spectrum β-lactamase (ES-
BL)-producing Klebsiella pneumoniae constitutes one of 
the most common Gram-negative bacteria showing resis-
tance to multiple antibiotics worldwide. These opportu-
nistic pathogens carrying multiple antibiotic resistance 
genes are highly recurrent and are responsible for nosoco-
mial infections. The prevalence of ESBL-producing Kleb-
siella pneumoniae has been reported to be 17.7% to 30% 
in Korea1 and 23% of the K. pneumoniae produce Ambler 
Class A ESBLs, with predominant SHV-12 and CTX-M 
types (Kim et al., 2005).
Currently, massive parallel sequencing (MPS) is being in-
creasingly used in clinical microbiology laboratories. The 
advent of this technology has helped us to understand the 
complexity of the resistance encountered by pathogens 
during antibiotic therapy. 
This technology clarifies the mechanism offering re-
sistance through phenotypic and genotypic co-relation 
(Capobianchi et al., 2013; Drögemüller et al., 2010; Didelot 
et al., 2012). The key objective of our study was to charac-
terize the mechanism responsible for the multidrug resis-
tance in ESBL-producing K. pneumoniae ST11 by using 
whole genome sequence analysis.
MATERIALS AND METHODS
Bacterial strain
K. pneumoniae was isolated from the blood culture of a 
70-year-old patient admitted to the intensive care unit 
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SUMMARY
The aim of this work was to investigate the mechanism responsible for multidrug resistance in ST11 Kleb-
siella pneumoniae YMC 2013/7/B3993 containing multiple copies of ESBL genes using multiple parallel 
sequencing technology. In-depth analysis of the strain revealed multiple copies of ESBL genes, 2 copies 
of blaSHV-12 and 1 copy of blaCTX-M-15. Furthermore, 1 copy of blaOXA-9 and 3 copies of blaTEM-1 were found. The 
insertion of Tn1331 was detected, which consisted of blaOXA-9, blaTEM-1, aac(6’)-lb-cr, and aadA1 genes. The 
acquisition of multiple copies of resistance genes was due to the insertion of transposons in the bacterial 
genome and plasmid. The genotypic analysis revealed that the isolates belonging to ST11 showed severe 
resistance phenotypes and greater dissemination potential. To the best of our knowledge, this is the first 
report demonstrating multiple copies of same ESBL genes in K. pneumoniae ST11 isolate. Furthermore, 
massive parallel sequencing studies of genetic factors to enhance the fitness of this type strain would be 
warranted to determine whether ST11 K. pneumoniae can spread the KPC-type gene.
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with bacterial meningitis and chronic renal failure from a 
tertiary care university affiliated hospital in Seoul, Korea. 
Bacteria identification was performed using VITEK 32 GN 
system (BioMérieux, Marcy l’Etoile, France), and was con-
firmed using the direct colony method with MALDI-TOF 
MS (Bruker Daltonics, Bremen, Germany).
Susceptibility tests, MIC determinations  
and conjugation studies 
Antibiotic susceptibility was tested using the disc diffu-
sion method containing piperacillin, ampicillin, piperacil-
lin-tazobactam, ceftazidime, cefepime, imipenem, mero-
penem, ciprofloxacin, ceftazidime-clavulanate, ampicil-
lin-sulbactam and aztreonam on Mueller-Hinton agar, ac-
cording to the Clinical and Laboratory Standards Institute 
(CLSI) guidelines. 
The MICs were determined by agar-dilution technique, 
and results were interpreted according to the CLSI guide-
lines. Screening of ESBL and AmpC β-lactamase produc-
tion was carried out by double disk synergy test as de-
scribed previously (Mohanty et al., 2009; Jennifer et al., 
2005). Conjugation experiments were carried out using E. 
coli J53 (F− met pro Azir) as the recipient. Transconjugants 
were selected on Mueller-Hinton agar plates containing 2 
mg/L of cefotaxime and ceftazidime with 100 mg/L of so-
dium azide.
DNA isolation and Ion Torrent PGM sequencing
Genomic DNA and plasmid DNA were isolated using Wiz-
ard Genomic DNA purification Kit (Promega, Madison, 
WI, USA) and Plasmid plus Midi Kit (Qiagen, Valencia, 
CA, USA), respectively. DNA concentration was estimated 
using Qubit dsDNA BR assay kit (Molecular Probes, Eu-
gene, OR, USA). Whole genome library was performed us-
ing Ionplus Fragment Library Kit and emulsion PCR was 
carried out using the Ion PGM Template OT2 400 kit (Life 
technologies, Carlsbad, CA, USA) according to the man-
ufacturer’s instructions. Sequencing of the libraries was 
carried out on a 318 chip v2 using the Ion Torrent PGM 
system and Ion Sequencing 400 kit (Life technologies, 
Carlsbad, CA, USA).  
Sequence assembly, annotation, typing and resistome 
analysis
Reads from the Ion Torrent PGM system were assembled 
using MIRA plug-in using Ion Torrent software. Annota-
tions were performed using the RAST annotation pipeline 
with manual scrutiny. Genomic analysis was performed 
using Geneious pro (Biomatters Ltd., AK, New Zealand). 
Multilocus sequence typing was performed by using MLST 
1.7 web interface (https://cge.cbs.dtu.dk/services/MLST/) 
and confirmed using Institute Pasteur MLST databases. 
Resistance genes were screened using Resfinder (https://
cge.cbs.dtu.dk/services/ResFinder/) and further verified 
using NCBI BLAST. 
Analysis of OMPs
Bacterial cells were grown in high-osmolarity MHB to 
the logarithmic phase and were lysed by sonication. Un-
broken cells were separated by centrifugation at 3,000 g 
for 5 minutes and outer membrane proteins (OMPs) were 
extracted with sodium lauroyl sarcosinate and recovered 
by ultracentrifugation, as described previously. The OMP 
profiles were determined using SDS-PAGE by Mini-Pro-
tean TGX gels followed by Coomassie blue staining (Bio-
Rad, Hercules, CA, USA).
Phylogenetic analysis 
The genome of YMC 2013/7/B3993 strain was used for 
phylogenetic analysis, along with 183 other Klebsiella spp. 
reference genomes that were available in NCBI as of No-
vember 2014. Ridom SeqSphere+ (Ridom GmbH, Germa-
ny) was used for the MLST and core-genome MLST anal-
ysis.
RESULTS
The K. pneumoniae YMC 2013/7/B3993 strain was resis-
tant to piperacillin, piperacillin-tazobactam, ceftazidime, 
amikacin, cefepime, cefoxitin, ciprofloxacin ampicil-
lin, ampicillin-sulbactam and susceptible to imipenem, 
meropenem and ceftazidime-clavulanate (Table 1). Using 
911,427 reads, we assembled the reads into 5,908,460 bp 
Table 1 - Antibiotic susceptibility of K. pneumoniae YMC 2013/7/B3993 with its genotypic explanation for the resistance 
observed. 
Antibiotics Class MIC (mg/L)/ Interpretation Enzymes/factors conferring resistance (gene locations*)
Piperacillin Ureidopenicillin 256/ R TEM-1(p/c)
Piperacillin-tazobactam Ureidopenicillin+BLI 128/ R TEM-1(p/c)
Ceftazidime Cephalosporin 256/ R TEM-1
(p), SHV-12(p/c), CTX-M-15(p),  
Loss of OmpK35 and OmpK36 
Cefepime Cephalosporin 94/ R TEM-1(p), SHV-12(p/c), CTX-M-15(p)
Imipenem Carbapenem 0.25/ S -
Meropenem Carbapenem 0.25/ S -
Ciprofloxacin Quinolone 128/ R QnrB66(p), OqxA(p/c), OqxB(p/c), Aac(6’)-lb-Cr(p/c)
Ceftazidime-clavulanate Cephalosporin+BLI 1/ S -
Cefoxitin Cephalosporin 32/ R TEM-1(p/c), Loss of OmpK35 and OmpK36
Ampicillin Aminopenicillin 256/ R TEM-1(p/c)
Ampicillin -sulbactam Aminopenicillin/BLI 128/ R TEM-1(p/c)
*(p) indicates the location of genes in plasmid and (p/c) indicates the location of the genes either in plasmid or chromosome. BLI, β-lactamase inhibitor. 
R.D. Souza, N.A. Pinto, I. Hwang, et al.40
chromosome with 188 contigs, consisting 5,714 coding 
sequences and 114 RNAs (33 rRNA and 81 tRNA). The 
average G+C content of the chromosome was 57%. This 
Whole Genome Shotgun project was deposited at DDBJ/
ENA/GenBank under the accession no. LDWV00000000. 
In-depth analysis revealed multiple copies of ESBL genes 
including two copies of blaSHV-12 and one copy of blaC-
TX-M-15 genes. In addition, we also found one copy of bla-
OXA-9 and three copies of blaTEM-1. This strain belonged to 
ST11 which was confirmed by analyzing the housekeeping 
genes for MLST (Figure 1). An insertion of Tn1331 was 
detected, which carried blaOXA-9, blaTEM-1, aac(6’)-lb-cr and 
aadA1 genes. 
Thus genotypic and phenotypic relationships are sum-
marized in Table 1. Ureidopenicillin and aminopenicil-
lin resistance is predominantly offered by TEM-1 gene, 
which is likely a baseline overproduction due to either 
alteration in the gene expression or increase in the copy 
numbers in the plasmid as described below. blaSHV-12 and 
blaCTX-M-15 are the ESBL determinants which confer re-
sistance to 1st, 2nd and 3rd generation cephalosporins. 
MIC of ciprofloxacin in the strain was notably high, 128 
mg/L, which might be due to the additive effect of both 
quinolone resistance-determining regions (QRDR) and 
plasmid-mediated quinolone resistance (PMQR). Muta-
tions in QRDR were observed at Ser83Ile and Ser80Ile 
in gyrA and parC genes, respectively and PMQR analysis 
indicates the presence of aac(6′)-lb-cr and qnrB, along 
with the genes for efflux pumps oqxA and oqxB. In sili-
co analysis of the strain confirmed the presence of ompA 
porin gene alone, which was confirmed using SDS-PAGE 
(Data not shown). ompK35 gene was interrupted by IS1 
and OmpK36 (OmpK36_v1 variant) with the amino acid 
substitution at Arg357His with a nucleotide substitution 
from A to T at -10 box, hindering its expression result-
ing in cefoxitin resistance. The prominent virulent genes 
found in other Enterobacteriaceae such as magA and 
rmpA gene and RNA methylases such as apmA, armA, 
armA2, rmtA and rmtB were absent in K. pneumoniae 
YMC 2013/7/B3993. However, virulence-associated Vag-
CD operon was present. The strain also consists of uge 
(UDP galacturonate 4-epimerase), Htra, PfrB and ccl 
genes were present with iron acquisition yersiniabactin 
synthesis enzyme and yersiniabactin siderophore biosyn-
thetic protein. 
Conjugation studies were performed to localize the re-
sistance genes and to determine the transferable ability 
of resistance genes between the strains. In spite of re-
peated attempts only one plasmid was transconjugated 
that was resistant to cefotaxime and ceftazidime. Resis-
tance transfer was confirmed by comparing the antibiot-
ic zone diameter between parent strain, E. coli J53 and 
the transconjugant (Data not shown). E-test indicated 
that the MIC of ceftazidime, cefotaxime and ciprofloxa-
cin was higher in transconjugant (CAZ-24 mg/L; FOX-32 
mg/L; CIP-0.19 mg/L) when compared to the Wild type E. 
coli J53 (CAZ-1 mg/L; FOX-0.25 mg/L; CIP-0.0.023 mg/L). 
Massive parallel sequencing of this plasmid revealed the 
presence of blaCTX-M-15, blaTEM-1, strA, strB, qnrB66, sul2 
and dfrA14 indicating that the β-lactamases and amino-
glycoside resistance determinants were encoded in plas-
mids that could have been transferred to Escherichia coli 
by conjugation. The localization of another ESBL gene 
blaSHV-12 was not clear. However we could see two copies 
of blaSHV-12 gene in strain YMC 2013/7/B3993, of which 
one was flanked by IS26. Both copies of this gene were 
confirmed using PCR and analysis of the nucleotides sur-
rounding both the blaSHV-12 genes (Figure 2). The average 
G+C content of the isolated plasmid was 50% with 2,770 
coding sequences and 23 RNAs. The whole genome se-
quence of conjugated plasmid was mapped against the 
E. coli J53 and the genomic DNA contamination which 
Figure 1 - Klebsiella pneumo-
niae phylogeny: Whole-genome 
phylogeny of YMC 2013/7/
B3993 relative to other strains. 
The tree demonstrates the ge-
nome of YMC 2013/7/B3993 is 
similar to other sequenced ge-
nomes i.e. JM45, HS11286 and 
ATCC BAA2146, all belonging to 
ST11 clone of K. pneumoniae.
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might have occurred during DNA extraction was careful-
ly removed from the parent strain. 
Resistance genes were further examined for its relation-
ship with other strains. The gene aac(6′)-Ib-cr, aadA1, bla-
OXA-9, and blaTEM-1 were present in close proximities within 
the structure of Tn1331. The GenBank indicated that this 
was identical to the multi resistance plasmid pJHCMW1 
(Genbank accession number AF479774) in K. pneumoni-
ae isolated from neonates with meningitis in 1986 (Woloj 
et al., 1986). However, this plasmid was not transferred 
in spite of repeated attempts. The amikacin resistance 
intrinsic to the plasmid pJHCMW1 was also noticed in 
YMC 2013/7/B3993, which must have been contributed 
from the same plasmid mentioned above.
DISCUSSION
Outbreaks of ESBL-producing K. pneumoniae strains are 
a major concern in nosocomial infections. ESBLs are 
enzymes manifesting considerable hydrolytic activity on 
a wide variety of β-lactam antibiotics including oxyimi-
no-cephalosporins and aztreonam (Shahid et al., 2004). 
Poor hygiene and improper handling of pathogenic strains 
has led to emerging resistance in the developing countries. 
As a result, strains once susceptible have evolved as resis-
tant strains (Laxminarayan et al., 2006). 
To date, 3 strains belonging to ST11 have been sequenced, 
which contain both ESBL and carbapenemase genes. 
Core-genome sequence typing revealed that YMC 2013/7/
Figure 2 - Contigs carrying the 
dual copy of ESBL Resistance 
Genes in YMC 2013/7/B3993 K. 
pneumoniae: Contigs carrying 
the Dual copy of SHV-12 ESBL 
resistance genes flanked by mo-
bile elements (orange arrows).
Figure 3 - Core-Genome MLST 
of YMC 2013/7/B3993 and 
closely related K. pneumoniae 
strains: Core-genome MLST of 
YMC 2013/7/B3993 with oth-
er closely related strains from 
ST11 and ST12. Tree created 
with task template K. pneu-
moniae+3597 targets HS11286 
with K. pneumoniae accesso-
ry 1628 targets HS11286. Our 
strain shares close relationship 
with other 3 ST11 K. pneumo-
niae consisting of Carbapene-
mase gene along ESBLs.
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B3993 falls in a clad containing fellow ST11 strains 
such as ATCC BAA-2146 (blaNDM-1 with blaCTX-M-15), JM45 
(contains blaKPC-2 with blaCTX-M-24) and HS11286 (contains 
blaKPC-2 with blaCTX-M-14); and this clad is located close to 
ST258 and ST512 strains (Figure 3). Interestingly, the 
three resistance clads contain the maximum number of 
resistance genes including ESBLs, AmpC β-lactamases 
and carbapenemases (Table 2). 
The combination of carbapenemase and ESBL genes in 
ST11 clones indicates that the strains with only ESBL 
Figure 4 - Comparison of plasmid resistome: Transconjugated plasmid carrying blaCTX-M-15 and blaTEM-1 was sequenced 
and compared with other plasmids. 13.6Kb of the plasmid shares 100% identity with the other plasmids found in K. pneu-
moniae, E. coli and Salmonella enterica.
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BAA214 (PRJNA138848) 11 • • • • • • • • • • • • • • • • • • •
JM45 (PRJNA215235 11 • •  • • • • • • • • • • • • • • • • • •
YMC2013/7/B3993 11 • • • • • • • • • • • • • • • • • • • •
KPNIH1(PRJNA73191 258 • • • • • • • • • • • • • • • • • •
K30BO(PRJNA180981) 512 • • • •  • • • • • • • •
KpQ3 (PRJNA182046) 256 • • • • • • • • • • • • • • • • • • • • • • •
MGH78578 (PRJNA57619) 38 • • • • • • • • • • • • • • • • • • • •
NTUHK2044 (PRJNA59073) 23 • • • • •   • •
SB3432 (PRJNA203334 67 • • • • •
ATCC13884 (PRJNA41361)  67 • • • • • • •
342 (PRJNA59145)  146 • •
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genes can acquire the carbapenemase genes in future. 
Tóth et al. reported that ST11 and ST258 belong to the 
clone complex CC258, along with ST 270, ST340, ST379, 
ST407 and ST418 (Tóth et al., 2010). Epidemiological 
data indicate that CC258 spread rapidly across the world 
in a similar fashion as the CC17 of vancomycin-resistant 
Enterococcus faecium and CC22 of carbapenem-resistant 
Acinetobacter baumannii (Willems et al., 2005; Fu et al., 
2010). From this we can conclude that the ST11 clone is 
a good colonizer to capture the plasmids, which results 
in multiple resistances. 
Previous studies reported that blaCTX-M-14 or blaCTX-M-15 were 
notoriously detected in most K. pneumoniae isolates 
in South Korea. YMC 2013/7/B3993 strain can be now 
termed a unique ESBL strain containing multiple copies 
of ESBL gene. 
Transconjugation studies confirmed the presence of ESBL 
gene blaCTX-M-15 which is flanked by mobile elements like 
Tn2 and transposase ISCR2. Comparative genome studies 
showed that the 13.6kb of this plasmid was identical to the 
K. pneumoniae plasmids, p6234, pHg, pKPX-2, Salmonella 
enterica plasmid pSTm-A54560 and E. coli pPGRT46 iso-
lated in Columbia, USA, Taiwan, Sub-Saharan Africa and 
Nigeria respectively (Figure 4). 
The non-conjugated plasmid in our strain was identical to 
pJHCMW1, a plasmid isolated from an outbreak strain in 
USA in 1986. Thus, global spread of this resistance is ob-
served and worrisome due to the mobility of this plasmid 
between genus levels and uncommon broad host range 
dissemination. 
To our knowledge, this is the first study demonstrating 
the massive parallel sequencing of ST11 strain containing 
multiple ESBL genes. Expansion of ST11 clones and plas-
mids that have acquired the transposons seems to have 
fueled dissemination of the KPC-type gene.
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